The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Volume 337:69-77 July 10, 1997 Number 2
NextNext

Trial of Calcium to Prevent Preeclampsia
Richard J. Levine, M.D., John C. Hauth, M.D., Luis B. Curet, M.D., Baha M. Sibai, M.D., Patrick M. Catalano, M.D., Cynthia D. Morris, Ph.D., Rebecca DerSimonian, Sc.D., Joy R. Esterlitz, M.S., Elizabeth G. Raymond, M.D., Diane E. Bild, M.D., John D. Clemens, M.D., Jeffrey A. Cutler, M.D., Marian G. Ewell, Steven A. Friedman, Robert L. Goldenberg, Sig-Linda Jacobson, Gary M. Joffe, M.D, Mark A. Klebanoff, and Alice S. Petrulis, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Previous trials have suggested that calcium supplementation during pregnancy may reduce the risk of preeclampsia. However, differences in study design and a low dietary calcium intake in the populations studied limit acceptance of the data.

Methods We randomly assigned 4589 healthy nulliparous women who were 13 to 21 weeks pregnant to receive daily treatment with either 2 g of elemental calcium or placebo for the remainder of their pregnancies. Surveillance for preeclampsia was conducted by personnel unaware of treatment-group assignments, using standardized measurements of blood pressure and urinary protein excretion at uniformly scheduled prenatal visits, protocols for monitoring these measurements during the hospitalization for delivery, and reviews of medical records of unscheduled outpatient visits and all hospitalizations.

Results Calcium supplementation did not significantly reduce the incidence or severity of preeclampsia or delay its onset. Preeclampsia occurred in 158 of the 2295 women in the calcium group (6.9 percent) and 168 of the 2294 women in the placebo group (7.3 percent) (relative risk, 0.94; 95 percent confidence interval, 0.76 to 1.16). There were no significant differences between the two groups in the prevalence of pregnancy-associated hypertension without preeclampsia (15.3 percent vs. 17.3 percent) or of all hypertensive disorders (22.2 percent vs. 24.6 percent). The mean systolic and diastolic blood pressures during pregnancy were similar in both groups. Calcium did not reduce the numbers of preterm deliveries, small-for-gestational-age births, or fetal and neonatal deaths; nor did it increase urolithiasis during pregnancy.

Conclusions Calcium supplementation during pregnancy did not prevent preeclampsia, pregnancy-associated hypertension, or adverse perinatal outcomes in healthy nulliparous women. (N Engl J Med 1997;337:69 -76.)


Source Information

From the Division of Epidemiology, Statistics, and Prevention Research, National Institute of Child Health and Human Development, Bethesda, Md. (R.J.L., R.D., E.G.R., J.D.C.); the Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham (J.C.H.); the Department of Obstetrics and Gynecology, University of New Mexico Health Sciences Center, Albuquerque (L.B.C.); the Department of Obstetrics and Gynecology, University of Tennessee College of Medicine, Memphis (B.M.S.); the Department of Obstetrics and Gynecology, MetroHealth Medical Center, Case Western Reserve University, Cleveland (P.M.C.); the Department of Medicine, Oregon Health Sciences University, Portland (C.D.M.); the Emmes Corporation, Potomac, Md. (J.R.E.); Family Health International, Research Triangle Park, N.C. (E.G.R.); and the Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, Md. (D.E.B., J.A.C.). Other authors were Marian G. Ewell, Sc.D. (Emmes Corp., Potomac, Md.), Steven A. Friedman, M.D. (University of Tennessee College of Medicine, Memphis), Robert L. Goldenberg, M.D. (University of Alabama at Birmingham), Sig-Linda Jacobson, M.D. (Oregon Health Sciences University, Portland), Gary M. Joffe, M.D. (University of New Mexico Health Sciences Center, Albuquerque), Mark A. Klebanoff, M.D. (National Institute of Child Health and Human Development, Bethesda, Md.), and Alice S. Petrulis, M.D. (MetroHealth Medical Center, Cleveland).

Address reprint requests to Dr. Levine at the Division of Epidemiology, Statistics, and Prevention Research, National Institute of Child Health and Human Development, National Institutes of Health, Bldg. 6100, Rm. 7B03, Bethesda, MD 20892-7510.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.